Literature DB >> 4026227

Postoperative contrast enhancement in patients with brain tumor.

J G Cairncross, J H Pexman, M P Rathbone, R F DelMaestro.   

Abstract

Contrast enhancement resulting from surgical trauma may mimic residual enhancing tumor, thereby complicating the interpretation of postoperative computed tomographic scans. We assessed the natural history of postoperative enhancement in 10 patients with brain tumor. Contrast enhancement distinguishable from residual enhancing tumor appeared along the operative margin following tumor resections but not lobectomies. Enhancement appeared as early as the fifth postoperative day, was most intense at two weeks, and persisted for several months. Prior to the fifth postoperative day, enhancement reflected residual tumor. Edema and artifacts were more prominent on the first and second postoperative days than on the third and fourth. We recommend that postoperative computed tomographic scans to assess residual enhancing tumor be performed on the third or fourth postoperative day. This timing avoids postoperative enhancement and minimizes interpretative difficulties caused by artifacts.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4026227     DOI: 10.1002/ana.410170607

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  30 in total

1.  Surgically induced intracranial contrast enhancement: potential source of diagnostic error in intraoperative MR imaging.

Authors:  M Knauth; N Aras; C R Wirtz; A Dörfler; T Engelhorn; K Sartor
Journal:  AJNR Am J Neuroradiol       Date:  1999-09       Impact factor: 3.825

Review 2.  Positron emission tomography and the central nervous system.

Authors:  R O Robinson; C D Ferrie; M Capra; M N Maisey
Journal:  Arch Dis Child       Date:  1999-09       Impact factor: 3.791

Review 3.  Toward a cure for infants with brain tumours: the challenge for the 1990's.

Authors:  P M Zeltzer
Journal:  Br J Cancer Suppl       Date:  1992-08

4.  Changes in glucose uptake by malignant gliomas: preliminary study of prognostic significance.

Authors:  J M Rozental; R L Levine; R J Nickles
Journal:  J Neurooncol       Date:  1991-02       Impact factor: 4.130

5.  MRI and thallium-201 SPECT in the prediction of survival in glioma.

Authors:  Maaike J Vos; Johannes Berkhof; Otto S Hoekstra; Ingeborg Bosma; Eefje M Sizoo; Jan J Heimans; Jaap C Reijneveld; Esther Sanchez; Frank J Lagerwaard; Jan Buter; David P Noske; Tjeerd J Postma
Journal:  Neuroradiology       Date:  2011-07-14       Impact factor: 2.804

6.  Tumor regrowth between surgery and initiation of adjuvant therapy in patients with newly diagnosed glioblastoma.

Authors:  Andrea Pirzkall; Colleen McGue; Suja Saraswathy; Soonmee Cha; Raymond Liu; Scott Vandenberg; Kathleen R Lamborn; Mitchel S Berger; Susan M Chang; Sarah J Nelson
Journal:  Neuro Oncol       Date:  2009-12       Impact factor: 12.300

7.  Correlation of intra-operative ultrasound with histopathologic findings after tumour resection in supratentorial gliomas. A method to improve gross total tumour resection.

Authors:  M Woydt; A Krone; G Becker; K Schmidt; W Roggendorf; K Roosen
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

Review 8.  Treatment-related changes in glioblastoma: a review on the controversies in response assessment criteria and the concepts of true progression, pseudoprogression, pseudoresponse and radionecrosis.

Authors:  P D Delgado-López; E Riñones-Mena; E M Corrales-García
Journal:  Clin Transl Oncol       Date:  2017-12-07       Impact factor: 3.405

9.  Spurious leptomeningeal enhancement on immediate post-operative MRI for paediatric brain tumours.

Authors:  Elysa Widjaja; Daniel J A Connolly; Sylvia Gatscher; John McMullen; Paul D Griffiths
Journal:  Pediatr Radiol       Date:  2004-11-13

Review 10.  Neuroradiologic review in pediatric brain tumor studies.

Authors:  Monika Warmuth-Metz; Brigitte Bison; Susanne Leykamm
Journal:  Klin Neuroradiol       Date:  2009-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.